日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

撤稿声明：BICC1通过诱导不依赖于VEGF的血管生成来驱动胰腺癌进展。

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02561-9
Huang, Chongbiao; Li, Hui; Xu, Yang; Xu, Chao; Sun, Huizhi; Li, Zengxun; Ge, Yi; Wang, Hongwei; Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Yang, Shengyu; Sun, Peiqing; Liu, Zhe; Liu, Jing; Chang, Antao; Hao, Jihui
血管生成
胰腺癌
VEGF
肿瘤
EGF
肿瘤免疫
发表日期：2026
文献求助 收藏

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer

靶向损伤相关巨噬细胞中的GPR34可增强抗肿瘤免疫力并提高苏鲁替尼在胰腺癌中的疗效

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02641-4
Guo, Xiaofan; Liu, Yuxiao; Li, Tianchen; An, Xiaopeng; Song, Yuning; Xu, Peijun; Huang, Jing; Zou, Yiping; Xu, Bohang; Xie, Yongjie; Li, Zekun; Meng, Chenyang; Zhao, Tiansuo; Wang, Xiuchao; Wang, Hongwei; Gao, Chuntao; Zhou, Xuan; Yu, Jun; Gao, Song; Hao, Jihui
胰腺癌
免疫/内分泌
细胞生物学
巨噬细胞
巨噬细胞
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中，NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇：一项随机、开放标签的 II 期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68409-0
Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance

线粒体钙单向转运蛋白通过谷胱甘肽介导的干性维持驱动胰腺癌的化疗耐药性

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202507346
Li, Zekun; Meng, Chenyang; Shen, Guangcong; Shan, Yueying; Wang, Junjin; Abudukeremu, Diliyaer; Zhao, Rui; Ni, Bo; Xu, Chao; Guo, Xiaofan; Yu, Jun; Wang, Kaiyuan; Yang, Shengyu; Li, YunZhan; Xie, Yongjie; Zhou, Tianxing; Hao, Jihui; Wang, Xiuchao
胰腺癌
肿瘤
线粒体
肿瘤免疫
发表日期：2026
文献求助 收藏

Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells.

伤害感受器神经元通过与癌症相关成纤维细胞相互作用和抑制自然杀伤细胞来促进 PDAC 进展和癌症疼痛

期刊:Cell Research
影响因子:25.9
doi:10.1038/s41422-025-01098-4
Wang Kaiyuan, Ni Bo, Xie Yongjie, Li Zekun, Yuan Limei, Meng Chenyang, Zhao Tiansuo, Gao Song, Huang Chongbiao, Wang Hongwei, Ma Ying, Zhou Tianxing, Feng Yukuan, Chang Antao, Yang Chao, Yu Jun, Yu Wenwen, Zang Fenglin, Zhang Yanhui, Ji Ru-Rong, Wang Xiuchao, Hao Jihui
神经科学
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Prime editor with rational design and AI-driven optimization for reverse editing window and enhanced fidelity

主编辑器采用合理的设计和人工智能驱动的优化，可实现反向编辑窗口和更高的保真度。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-60495-w
Yang, Chao; Fang, Qingxiao; Li, Mengyu; Zhang, Jin; Li, Rui; Zhou, Tianxing; Wang, Keshan; Deng, Jie; Wang, Xiuchao; Huang, Chongbiao; Feng, Yukuan; Zhang, Xiaoping; Shi, Lei; Bi, Changhao; Zhang, Xueli; Yu, Jun; Hao, Jihui
发表日期：2025
文献求助 收藏

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters

胰腺癌综合预处理分层系统：结合解剖可切除性和肿瘤生物学参数

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0213
Gao, Song; Liang, Yuexiang; Yu, Jun; Chang, Shaofei; Wang, Hongwei; Zhao, Tiansuo; Wang, Xiuchao; Man, Quan; Li, Zhifei; Zou, Yiping; Jiang, Kuirong; Gao, Chuntao; Hao, Jihui
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma

识别壶腹腺癌根治性切除术后的隐匿性高危特征和分层管理策略

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0181
Ma, Xiaoqing; Meng, Chenyang; Shi, Xuejing; Zhang, Zhaoyu; Li, Qiuli; Wang, Hongwei; Liang, Yuexiang; Gao, Song; Wang, Xiuchao; Gao, Chuntao; Wang, Jian; Ma, Weidong; Feng, Yukuan; Li, Shuo; Chen, Xingyun; Li, Wei; Shi, Shangheng; Zhou, Tianxing; Yu, Jun; Hao, Jihui
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 通过阻断 PI3K/AKT/HIF-1α 通路发挥抗胰腺癌的活性。

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0058
Xu Chao, Li Zekun, Shan Yueying, She Chunhua, Yang Yanfang, Zhou Tianxing, Xie Yongjie, Ni Bo, Meng Chenyang, Shen Guangcong, Fu Boyang, Sheng Guannan, Wu Liangliang, Pei Jinlong, Zhao Tiansuo, Gao Song, Wang Hongwei, Deng Chengqi, Wang Kaiyuan, Chang Antao, Huang Chongbiao, Shi Lei, Yang Shengyu, Yu Jun, Hao Jihui, Wang Xiuchao
胰腺癌
信号转导
AKT
PI3K/Akt
发表日期：2025
文献求助 收藏

HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma

HCAR2 调控免疫抑制微环境并决定食管鳞状细胞癌对检查点抑制剂的反应性

期刊:Biological Procedures Online
影响因子:4.3
doi:10.1186/s12575-025-00305-1
Li, Zekun; Shen, Guangcong; Ma, Xiaoqing; Meng, Chenyang; Abudukeremu, Diliyaer; Zhao, Rui; Chen, Zuoyu; Song, Qiang; Guo, Xiaofan; Zhou, Tianxing; Xu, Chao; Ni, Bo; Shan, Yueying; Fu, Boyang; Chen, Yiheng; Jiang, Zhansheng; Xie, Yongjie; Wang, Kaiyuan; Wu, Liangliang; Wang, Xiuchao
Checkpoint
肿瘤
肿瘤免疫
信号转导
HCAR2
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏